Evaluation and management of incidentally discovered thyroid nodules

Surgical Oncology

Volumn 15, Issue 1, 2006, Pages 33-42

  Datta, Rajiv V ^a   Petrelli, Nicholas J ^b   Ramzy, Joseph ^b  

^a Division of Surgical Oncology and Head and Neck Surgery   (United States)

^b HELEN F GRAHAM CANCER CENTER   (United States)

Author keywords

Biopsy; Cancer; Nodule; Thyroid; Ultrasonography

Indexed keywords

ALCOHOL; CALCITONIN; FLUORODEOXYGLUCOSE F 18; IODINE; LEVOTHYROXINE; MOLECULAR MARKER; RADIOACTIVE IODINE; THYROGLOBULIN; THYROTROPIN;

ARTICLE; ASPIRATION BIOPSY; AUTOIMMUNE DISEASE; BENIGN TUMOR; BONE DENSITY; CALCITONIN BLOOD LEVEL; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CLINICAL EXAMINATION; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL TUMOR; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; ECHOGRAPHY; ENVIRONMENTAL EXPOSURE; EXTERNAL BEAM RADIOTHERAPY; FOLLICULAR CARCINOMA; GARDNER SYNDROME; GENE MUTATION; GENETIC ASSOCIATION; GRAVES DISEASE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HUMAN; HYPERTHYROIDISM; IMMUNOHISTOCHEMISTRY; INCIDENTAL FINDING; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; NEEDLE BIOPSY; ONCOCYTOMA; PAPILLARY CARCINOMA; PATHOPHYSIOLOGY; POPULATION RESEARCH; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; SCLEROTHERAPY; SEX RATIO; SIDE EFFECT; SUBTOTAL THYROIDECTOMY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROID CYST; THYROID MEDULLARY CARCINOMA; THYROID NODULE; THYROID SCINTISCANNING; THYROID SURGERY; THYROIDITIS; THYROTROPIN BLOOD LEVEL;

ADULT; BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GOITER; HUMANS; IMMUNOHISTOCHEMISTRY; IODINE; MALE; MIDDLE AGED; RISK FACTORS; THYROID NEOPLASMS; THYROID NODULE; THYROXINE; TUMOR MARKERS, BIOLOGICAL;

EID: 33747882886     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2006.07.002     Document Type: Article

References (51)

1. Sriram U., and Patacsil L.M. Thyroid nodules. Disease Monthly 50 (2004) 486-526
2. Perlmutter M., and Slater S.L. Which nodular goiters should be removed; a physiologic plan for the diagnosis and treatment of nodular goiter. New England Journal of Medicine 255 (1956) 65-71
3. Shaha A.R. Controversies in the management of thyroid nodule. Laryngoscope 110 (2000) 183-193
4. Wong C.K., and Wheeler M.H. Thyroid nodules: rational management. World Journal of Surgery 24 (2000) 934-941
5. Hundahl S.A., Fleming I.D., Fremgen A.M., and Menck H.R. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer 83 (1998) 2638-2648
6. Hegedus L. Clinical practice. The thyroid nodule. New England Journal of Medicine 351 (2004) 1764-1771
7. Vander J.B., Gaston E.A., and Dawber T.R. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Annals of Internal Medicine 69 (1968) 537-540
8. Rojeski M.T., and Gharib H. Nodular thyroid disease. Evaluation and management. New England Journal of Medicine 313 (1985) 428-436
9. Kuma K., Matsuzuka F., Yokozawa T., Miyauchi A., and Sugawara M. Fate of untreated benign thyroid nodules: results of long-term follow-up. World Journal of Surgery 18 (1994) 495-498
10. DeGroot L., and Paloyan E. Thyroid carcinoma and radiation. A Chicago endemic. JAMA 225 (1973) 487-491
11. Shore R.E., Woodard E., Hildreth N., Dvoretsky P., Hempelmann L., and Pasternack B. Thyroid tumors following thymus irradiation. Journal of the National Cancer Institute 74 (1985) 1177-1184
12. Ron E., Modan B., Preston D., Alfandary E., Stovall M., and Boice Jr. J.D. Thyroid neoplasia following low-dose radiation in childhood. Radiation Research 120 (1989) 516-531
13. Sklar C., Whitton J., Mertens A., Stovall M., Green D., Marina N., et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. Journal of Clinical Endocrinology and Metabolism 85 (2000) 3227-3232
14. Kraimps J.L., Bouin-Pineau M.H., Mathonnet M., De C.L., Ronceray J., Visset J., et al. Multicentre study of thyroid nodules in patients with Graves' disease. British Journal of Surgery 87 (2000) 1111-1113
15. Mishra A., and Mishra S.K. Multicentre study of thyroid nodules in patients with Graves' disease. British Journal of Surgery 88 (2001) 313
16. Ravetto C., Colombo L., and Dottorini M.E. Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients. Cancer 90 (2000) 357-363
17. Duprez L., Parma J., van S.J., Rodien P., Sabine C., Abramowicz M., et al. Pathology of the TSH receptor. Journal of Pediatric Endocrinology & Metabolism 12 Suppl. 1 (1999) 295-302
18. Parma J., Duprez L., van S.J., Hermans J., Rocmans P., Van V.G., et al. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. Journal of Clinical Endocrinology and Metabolism 82 (1997) 2695-2701
19. van S.J., Parma J., Tonacchera M., Swillens S., Dumont J., and Vassart G. Somatic and germline mutations of the TSH receptor gene in thyroid diseases. Journal of Clinical Endocrinology and Metabolism 80 (1995) 2577-2585
20. Weiss R.E., and Lado-Abeal J. Thyroid nodules: diagnosis and therapy. Current Opinion in Oncology 14 (2002) 46-52
21. Kroll T.G., Sarraf P., Pecciarini L., Chen C.J., Mueller E., Spiegelman B.M., et al. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science 289 (2000) 1357-1360
22. Favus M.J., Schneider A.B., Stachura M.E., Arnold J.E., Ryo U.Y., Pinsky S.M., et al. Thyroid cancer occurring as a late consequence of head-and-neck irradiation. Evaluation of 1056 patients. New England Journal of Medicine 294 (1976) 1019-1025
23. Lawrence Jr. W., and Kaplan B.J. Diagnosis and management of patients with thyroid nodules. Journal of Surgical Oncology 80 (2002) 157-170
24. Singer P.A., Cooper D.S., Daniels G.H., Ladenson P.W., Greenspan F.S., Levy E.G., et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Archives of Internal Medicine 156 (1996) 2165-2172
25. Livadas D., Psarras A., and Koutras D.A. Malignant cold thyroid nodules in hyperthyroidism. British Journal of Surgery 63 (1976) 726-728
26. McCall A., Jarosz H., Lawrence A.M., and Paloyan E. The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters. Surgery 100 (1986) 1128-1132
27. Jarlov A.E. Observer variation in the diagnosis of thyroid disorders. Criteria for and impact on diagnostic decision-making. Danish Medical Bulletin 47 (2000) 328-339
28. Kim N., and Lavertu P. Evaluation of a thyroid nodule. Otolaryngologic Clinics of North America 36 (2003) 17-33
29. Kang K.W., Kim S.K., Kang H.S., Lee E.S., Sim J.S., Lee I.G., et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. Journal of Clinical Endocrinology and Metabolism 88 (2003) 4100-4104
30. Niccoli P., Wion-Barbot N., Caron P., Henry J.F., De M.C., Saint Andre J.P., et al. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. Journal of Clinical Endocrinology and Metabolism 82 (1997) 338-341
31. Mulligan L.M., Kwok J.B., Healey C.S., Elsdon M.J., Eng C., Gardner E., et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363 (1993) 458-460
32. Mazzaferri E.L. Management of a solitary thyroid nodule. New England Journal of Medicine 328 (1993) 553-559
33. Pacini F., Burroni L., Ciuoli C., Di C.G., and Guarino E. Management of thyroid nodules: a clinicopathological, evidence-based approach. European Journal of Nuclear Medicine and Molecular Imaging 31 (2004) 1443-1449
34. Greaves T.S., Olvera M., Florentine B.D., Raza A.S., Cobb C.J., Tsao-Wei D.D., et al. Follicular lesions of thyroid: a 5-year fine-needle aspiration experience. Cancer 90 (2000) 335-341
35. Stoler D.L., Datta R.V., Charles M.A., Block A.W., Brenner B.M., Sieczka E.M., et al. Genomic instability measurement in the diagnosis of thyroid neoplasms. Head and Neck 24 (2002) 290-295
36. Castro M.R., and Gharib H. Continuing controversies in the management of thyroid nodules. Annals of Internal Medicine 142 (2005) 926-931
37. Grant C.S., Hay I.D., Gough I.R., McCarthy P.M., and Goellner J.R. Long-term follow-up of patients with benign thyroid fine-needle aspiration cytologic diagnoses. Surgery 106 (1989) 980-985
38. Gharib H., and Goellner J.R. Fine-needle aspiration biopsy of the thyroid: an appraisal. Annals of Internal Medicine 118 (1993) 282-289
39. Hamburger J.I. Diagnosis of thyroid nodules by fine needle biopsy: use and abuse. Journal of Clinical Endocrinology and Metabolism 79 (1994) 335-339
40. Hegedus L. Thyroid ultrasound. Endocrinology and Metabolism Clinics of North America 30 (2001) 339-360
41. Alexander E.K., Hurwitz S., Heering J.P., Benson C.B., Frates M.C., Doubilet P.M., et al. Natural history of benign solid and cystic thyroid nodules. Annals of Internal Medicine 138 (2003) 315-318
42. Bennedbaek F.N., Perrild H., and Hegedus L. Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clinical Endocrinology 50 (1999) 357-363
43. Bennedbaek F.N., and Hegedus L. Management of the solitary thyroid nodule: results of a North American survey. Journal of Clinical Endocrinology and Metabolism 85 (2000) 2493-2498
44. Castro M.R., Caraballo P.J., and Morris J.C. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 87 (2002) 4154-4159
45. Sawin C.T., Geller A., Wolf P.A., Belanger A.J., Baker E., Bacharach P., et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. New England Journal of Medicine 331 (1994) 1249-1252
46. Surks M.I., Ortiz E., Daniels G.H., Sawin C.T., Col N.F., Cobin R.H., et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291 (2004) 228-238
47. Uzzan B., Campos J., Cucherat M., Nony P., Boissel J.P., and Perret G.Y. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 81 (1996) 4278-4289
48. Gharib H. Changing trends in thyroid practice: understanding nodular thyroid disease. Endocrine Practice 10 (2004) 31-39
49. Hegedus L., Nygaard B., and Hansen J.M. Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified?. Journal of Clinical Endocrinology and Metabolism 84 (1999) 756-760
50. Harach H.R., Franssila K.O., and Wasenius V.M. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer 56 (1985) 531-538
51. Ito Y., Uruno T., Nakano K., Takamura Y., Miya A., Kobayashi K., et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13 (2003) 381-387